Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, stands as an
immensely devastating and persistently relevant pathogen, claiming the lives of millions …

This article discusses the various blood interactions that may occur with various types of
nano drug-loading systems. Nanoparticles enter the blood circulation as foreign objects. On …

Nanoemulsions are liquid-in-liquid dispersion with a droplet size of about 100 nm. They
have a transparent appearance, high rate of bioavailability, and increased shelf life …

Introduction Nanoemulsion-based drug delivery approaches have witnessed massive
acceptance over the years and acquired a significant foothold owing to their tremendous …

Tuberculosis (TB), one of the deadliest contagious diseases, is a major concern worldwide.
Long-term treatment, a high pill burden, limited compliance, and strict administration …

Since the first patent for micro array patches (MAPs) was filed in the 1970s, research on
utilising MAPs as a drug delivery system has progressed significantly, evidenced by the …

Introduction TB is associated with high mortality and morbidity among infected individuals
and a high transmission rate from person to person. Despite the availability of vaccines and …

Mycobacterial cutaneous lesions are nonpathognomonic and clinical suspicion must be
confirmed by culture or molecular detection. Long-course multidrug treatment is required …

Introduction: Luteolin (LUT) is natural flavonoid with multiple therapeutic potentials and is
explored for transdermal delivery using a nanocarrier system. LUT loaded cationic …

The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium
tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist …